Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 17-25

  Ferlin, Alberto ^a   Ganz, Francesco ^a   Pengo, Manuel ^a   Selice, Riccardo ^a   Frigo, Anna Chiara ^a   Foresta, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; ESTROGEN RECEPTOR; GENOMIC DNA; MARKER; STEROID HORMONE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1E1; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CRYPTORCHISM; DNA POLYMORPHISM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; SEMINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID METABOLISM; TESTICULAR GERM CELL TUMOR; TESTIS TUMOR;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; AROMATASE; ARYLSULFOTRANSFERASE; CATECHOL O-METHYLTRANSFERASE; CRYPTORCHIDISM; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL DEHYDROGENASES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYDRO-LYASES; MALE; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMORPHISM, SINGLE NUCLEOTIDE; SEMINOMA; SULFOTRANSFERASES; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 77449149129     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0176     Document Type: Article

References (30)

1. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D et al. 2006 Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Human Molecular Genetics 15 443-451.
2. Czene K, Lichtenstein P & Hemminki K 2002 Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. International Journal of Cancer 99 260-266.
3. Ferlin A, Vinanzi C, Garolla A, Selice R, Zuccarello D, Cazzadore C & Foresta C 2006 Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clinical Endocrinology 65 606-610.
4. Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A & Foresta C 2007a Molecular and clinical characterization of Y chromosome microdeletions in infertile men: ten years experience in Italy. Journal of Clinical Endocrinology and Metabolism 92 762-770.
5. Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G & Foresta C 2007b Male infertility: role of genetic background. Reproductive Biomedicine Online 14 734-745.
6. Ferlin A, Pengo M, Selice R, Salmaso L, Garolla A & Foresta C 2008a Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility. Endocrine-Related Cancer 15 429-437.
7. Ferlin A, Zuccarello D, Zuccarello B, Chirico MR, Zanon GF & Foresta C 2008b Genetic alterations associated with cryptorchidism. Journal of the American Medical Association 300 2271-2276.
8. Figueroa JD, Sakoda LC, Graubard BI, Chanock S, Rubertone MV, Erickson RL & McGlynn KA 2008 Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes & Control 19 917-929.
9. Foresta C, Zuccarello D, Garolla A & Ferlin A 2008 Role of hormones, genes, and environment in human cryptorchidism. Endocrine Reviews 29 560-580.
10. Garolla A, Ferlin A, Vinanzi C, Roverato A, Sotti G, Artibani W & Foresta C 2005 Molecular analysis of the androgen receptor gene in testicular cancer. Endocrine-Related Cancer 12 645-655.
11. Giwercman A, Carlsen E, Keiding N & Skakkebaek NE 1993 Evidence for increasing incidence of abnormalities of the human testis: a review. Environmental Health Perspectives 101 65-71.
12. Giwercman A, Lundin KB, Eberhard J, Stahl O, Cwikiel M, Cavallin-Stahl E & Giwercman YL 2004 Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage. European Journal of Cancer 40 2152-2158.
13. Hemminki K & Li X 2004 Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. British Journal of Cancer 90 1765-1770.
14. Holl K, Lundin E, Surcel HM, Grankvist K, Koskela P, Dillner J, Hallmans G, Wadell G, Olafsdottir GH, Ogmundsdottir HM et al. 2009 Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study. International Journal of Cancer 124 2923-2928.
15. Horwich A, Shipley J & Huddart R 2006 Testicular germ-cell cancer. Lancet 367 754-765.
16. Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J et al. 2009 Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature Genetics 41 811-815.
17. Krausz C & Looijenga LH 2008 Genetic aspects of testicular germ cell tumors. Cell Cycle 7 3519-3524.
18. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA et al. 2005 The Y deletion gr/gr and susceptibility to testicular germ cell tumor. American Journal of Human Genetics 77 1034-1043.
19. Rajpert-De Meyts E 2006 Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Human Reproduction Update 12 303-323.
20. Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossâ SD et al. 2000 Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nature Genetics 24 197-200.
21. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, Renwick A, Hughes D, Hines S, Seal S et al. 2009 A genome-wide association study of testicular germ cell tumor. Nature Genetics 41 807-810.
22. Ross RW, Oh WK, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin ME, Regan MM, Kantoff PW & Freedman M 2008 Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer. Journal of Clinical Oncology 26 842-847.
23. Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ & De Vivo I 2004 HSD17B1 gene polymorphisms and risk of endometrial and breast cancer. Cancer Epidemiology, Biomarkers & Prevention 13 213-219.
24. Sharpe RM 2003 The 'oestrogen hypothesis'- where do we stand now? International Journal of Andrology 26 2-15.
25. Sharpe RM & Skakkebaek NE 2008 Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertility and Sterility 89 (Supplement 2) e33-e38.
26. Skakkebaek NE, Rajpert-De Meyts E & Main KM 2001 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction 16 972-978.
27. Starr JR, Chen C, Doody DR, Hsu L, Ricks S, Weiss NS & Schwartz SM 2005 Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiology, Biomarkers & Prevention 14 2183-2190.
28. Swerdlow AJ, De Stavola BL, Swanwick MA & Maconochie NE 1997 Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 350 1723-1728.
29. Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH & Arrundale J 1998 Trends in cancer incidence and mortality in Scotland: description and possible explanations. British Journal of Cancer 77 1-54.
30. Wohlfahrt-Veje C, Main KM & Skakkebæk NE 2009 Testicular Dysgenesis syndrome; fetal origin of adult reproductive problems. Clinical Endocrinology 71 459-465.